- Corporate Officers - G
- Goldan Keith A.
Insider Trading History of Goldan Keith A.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Goldan Keith A. since 2015.
This trader's CIK number is 1495411.
At the time of last reporting, Goldan Keith A. was the Chief Financial Officer of Syndax Pharmaceuticals Inc. (stock ticker symbol SNDX).
Also see all insider trading activities at Syndax Pharmaceuticals Inc.
Note that in the past
Goldan Keith A. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Fibrocell Science, Inc. (FCSC) by Goldan Keith A.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | FCSC | 2,000 | $12,660 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Optinose, Inc. (OPTN) by Goldan Keith A.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | OPTN | 0 | $0 | 4,617 | $9,741 | 0 | $0 |
2021 | OPTN | 0 | $0 | 3,462 | $11,594 | 0 | $0 |
2020 | OPTN | 2,500 | $9,742 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Syndax Pharmaceuticals Inc (SNDX) by Goldan Keith A.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | SNDX | 3,000 | $0 | 5,073 | $70,591 | 0 | $0 |
2024 | SNDX | 1,250 | $25,037 | 0 | $0 | 0 | $0 |
2023 | SNDX | 0 | $0 | 577 | $12,872 | 0 | $0 |
Insider trading activities at 3 companies by Goldan Keith A.:
1. Fibrocell Science, Inc. (FCSC)
2. Optinose, Inc. (OPTN)
3. Syndax Pharmaceuticals Inc (SNDX)
Table 1. Insider trading of Fibrocell Science, Inc. (FCSC) by Goldan Keith A.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-08-11 | FCSC | Buy | 2,000 | 6.33 | 12,660 |
Table 2. Insider trading of Optinose, Inc. (OPTN) by Goldan Keith A.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-03-16 | OPTN | Sale | 4,617 | 2.11 | 9,741 |
2021-12-16 | OPTN | Sale | 580 | 1.64 | 951 |
2021-09-16 | OPTN | Sale | 578 | 2.79 | 1,612 |
2021-03-15 | OPTN | Sale | 2,304 | 3.92 | 9,031 |
2020-09-23 | OPTN | Buy | 2,500 | 3.90 | 9,742 |
Table 3. Insider trading of Syndax Pharmaceuticals Inc (SNDX) by Goldan Keith A.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-07-16 | SNDX | Sale | 1,296 | 9.29 | 12,033 |
2025-05-19 | SNDX | Buy | 3,000 | .00 | 0 |
2025-02-10 | SNDX | Sale | 3,777 | 15.50 | 58,558 |
2024-06-14 | SNDX | Buy | 1,250 | 20.03 | 25,037 |
2023-06-13 | SNDX | Sale | 577 | 22.31 | 12,872 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Goldan Keith A.
(Chief Financial Officer of Syndax Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.